We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
TruSpine Technologies Plc | AQSE:TSP | Aquis Stock Exchange | Ordinary Share | GB00BMZCKL55 | Ordinary shares |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.60 | 0.80 | 2.20 | 1.60 | 1.35 | 1.60 | 0.00 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTSP
RNS Number : 6731C
TruSpine Technologies PLC
12 October 2022
TruSpine Technologies plc
("TruSpine" or the "Company")
Notice of Annual General Meeting
TruSpine Technologies plc (AQSE: TSP), the medical device company focused on the development of its pioneering "screwless", spinal (vertebral) stabilisation systems, announces that its Annual General Meeting ("AGM") for 2022 will be held at 9:00 am on Thursday 27 October 2022, at the Company's registered office, being Spectrum House, Af33, Beehive Ring Road, London Gatwick Airport, Gatwick, England, RH6 0LG.
The Notice of AGM is published and available on the "AGM" page on the Company's website ( https://investors.truspine.org/investors/agm ). A proxy form for the AGM is also available on the same web page.
Enquiries:
Truspine Technologies Plc Tel: +44 (0)20 3638 5025 Ian Roberts, CEO Cairn Financial Advisers LLP (AQSE Corporate Tel: +44 (0)20 7213 0880 Adviser) Liam Murray / Ludovico Lazzaretti Oberon Capital (Joint Broker) Tel: +44 (0)20 3179 5300 Mike Seabrook / Chris Crawford Peterhouse Capital Limited (Joint Tel: +44 (0)20 7469 0930 Broker & Financial Adviser) Lucy Williams / Duncan Vasey Walbrook PR (Financial Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 PR & IR) 741 001 Anna Dunphy truspine@walbrookpr.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFFLFFEEESESS
(END) Dow Jones Newswires
October 12, 2022 08:00 ET (12:00 GMT)
1 Year TruSpine Technologies Chart |
1 Month TruSpine Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions